Ian Johnston Acquires 4,250 Shares of Amrize (NYSE:AMRZ) Stock

Key Points

• CFO Ian Johnston bought 4,250 Amrize shares at an average of $58.94 on March 10, boosting his holdings 20.37% to 25,110 shares valued at about $1.48 million, according to an SEC filing.
• AMRZ traded at $58.03 with 1.19M shares changing hands; the stock has a 12‑month range of $44.12–$65.94, a market cap of roughly $32.1 billion and a P/E of 23.6.
• Analyst sentiment is largely positive: the consensus rating is a “Moderate Buy” with a $64.14 target, and several firms (including JPMorgan) have recently raised price targets—JPMorgan to $70 with an overweight rating.

Amrize Ltd (NYSE:AMRZ - Get Free Report) CFO Ian Johnston purchased 4,250 shares of the firm's stock in a transaction dated Tuesday, March 10th. The stock was acquired at an average cost of $58.94 per share, with a total value of $250,495.00. Following the purchase, the chief financial officer owned 25,110 shares of the company's stock, valued at approximately $1,479,983.40. This represents a 20.37% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Amrize Stock Performance

Shares of AMRZ traded down $1.14 during trading hours on Wednesday, reaching $58.03. 1,191,449 shares of the company's stock traded hands, compared to its average volume of 3,548,729. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $65.94. The business's fifty day simple moving average is $57.80 and its two-hundred day simple moving average is $53.59. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 1.10. The firm has a market capitalization of $32.10 billion and a price-to-earnings ratio of 23.60.

Amrize (NYSE:AMRZ - Get Free Report) last announced its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.59 by $0.03. The company had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.95 billion. The company's revenue was down .4% on a year-over-year basis.

Institutional Trading of Amrize

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. grew its position in Amrize by 5.6% in the fourth quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company's stock worth $1,722,500,000 after buying an additional 1,676,843 shares during the last quarter. Norges Bank purchased a new position in Amrize in the 4th quarter worth about $929,333,000. Dodge & Cox acquired a new stake in Amrize during the 2nd quarter worth about $622,085,000. Wellington Management Group LLP raised its holdings in Amrize by 48.8% during the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock worth $561,018,000 after buying an additional 3,809,133 shares during the period. Finally, Harris Associates L P purchased a new stake in Amrize during the fourth quarter valued at about $615,406,000.

Analyst Ratings Changes

AMRZ has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised their price objective on shares of Amrize from $60.00 to $70.00 and gave the company an "overweight" rating in a research note on Thursday, March 5th. Sanford C. Bernstein restated an "outperform" rating and issued a $70.00 target price on shares of Amrize in a research report on Thursday, December 18th. UBS Group increased their price target on Amrize from $53.00 to $57.00 and gave the company a "neutral" rating in a research note on Thursday, January 8th. Vertical Research began coverage on Amrize in a research note on Tuesday, November 25th. They issued a "hold" rating and a $54.00 price objective on the stock. Finally, Citigroup upped their price objective on Amrize from $63.00 to $67.00 and gave the company a "buy" rating in a report on Thursday, January 8th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $64.14.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.